PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Health

B-Vitamin Supplement Can Treat Psoriasis, a Skin Condition with No Cure

A cheap B‑vitamin pill shows promise in easing psoriasis symptoms, sparking hope for millions with the incurable skin disease

7sources
7articles
5velocity
+65%since first seen
17d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Recent studies and small human trials identified the vitamin derivative pantethine and other common nutritional supplements as potential treatments to ease psoriasis symptoms. Media coverage highlighted the possibility of an inexpensive pill for the skin condition, while also prompting expert examination regarding whether the potential treatment was too good to be true.

The story quieted without a definitive conclusion in the coverage.

Epilogue added 14d ago, after coverage quieted.

The brief

On October 31 2026 multiple outlets reported that pantethine, a derivative of the B‑vitamin pantothenic acid, reduced psoriasis symptoms in a small human trial. Researchers observed that participants experienced alleviation of the chronic skin condition after a course of the supplement. The trial, described only as “small,” involved human volunteers and was not a large‑scale study. Pantethine is already marketed as an inexpensive 31‑pence pill, making it a readily accessible option for patients facing a disease for which no cure currently exists. Coverage emphasized both the scientific finding and its consumer implications.

Genetic Engineering and Biotechnology News highlighted the trial results, while EurekAlert! reported that researchers identified the common nutritional supplement as a potential treatment. The Sun framed the discovery as hope for millions, referencing the pill’s low price. Themercury.com and StudyFinds noted that the supplement, already on the vitamin aisle, eases the condition. HELLO! featured a skin doctor questioning whether the 31‑pence pill could truly be a cure, and Good News Network ran a headline declaring the B‑vitamin supplement can treat psoriasis. Psoriasis is a chronic inflammatory disease that affects the skin and joints of a sizable portion of the global population.

Existing therapies range from topical steroids and phototherapy to biologic drugs that target immune pathways, yet none constitute a definitive cure. The condition’s prevalence and the high cost of advanced treatments have left many patients seeking affordable alternatives, a context that amplifies interest in any low‑cost, over‑the‑counter option that shows clinical benefit. Future reporting will focus on whether larger, controlled trials are launched to confirm pantethine’s efficacy and safety. Regulatory bodies may evaluate the supplement for formal therapeutic use, and dermatology guidelines could be updated if evidence expands. Market observers will watch pricing dynamics and potential shifts in prescription patterns as the medical community assesses the role of this vitamin derivative in managing psoriasis.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 14d ago.

Quick answers

What is pantethine?

Pantethine is a derivative of vitamin B5 (pantothenic acid) that is sold as a nutritional supplement.

What did the small human trial find?

The trial reported that participants experienced alleviation of psoriasis symptoms after taking pantethine.

What are the next steps mentioned in the coverage?

Researchers plan larger studies and regulators may assess the supplement’s suitability as a treatment for psoriasis.

Coverage (7)

Topics

Related trends

\n \n \n \n \n \n \n